Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weiming Xia

Showing results (21-30 of 152) with videos related to

Pageof 16
Sort By:
Archives of Neurology|October 14, 2009
Ten-year change in plasma amyloid beta levels and late-life cognitive declineOlivia I Okereke, Weiming Xia, Dennis J Selkoe, et al.
Metabolic Brain Disease|November 14, 2024
Individuals with SATB2-associated syndrome have impaired vitamin and energy metabolism pathwaysRoberto Collu, Yuri A Zarate, Weiming Xia, et al.
JAMA Neurology|May 3, 2016
Genomics of Alzheimer Disease: A ReviewRoger N Rosenberg, Doris Lambracht-Washington, Gang Yu, et al.
Frontiers in Molecular Neuroscience|August 28, 2020
Targeting Amyloidogenic Processing of APP in Alzheimer's DiseaseJing Zhao, Xinyue Liu, Weiming Xia, et al.
The Journal of Biological Chemistry|March 2, 2006
The cytosolic loop of the gamma-secretase component presenilin enhancer 2 protects zebrafish embryos from apoptosisHenrik Zetterberg, William A Campbell, Hong Wei Yang, et al.
Journal of Structural Biology|July 6, 2015
Molecular dynamics simulation study reveals potential substrate entry path into γ-secretase/presenilin-1Ren Kong, Shan Chang, Weiming Xia, et al.
The Journal of Biological Chemistry|May 13, 2010
A presenilin-1 mutation identified in familial Alzheimer disease with cotton wool plaques causes a nearly complete loss of gamma-secretase activityElizabeth A Heilig, Weiming Xia, Jie Shen, et al.
Journal of Alzheimer'S Disease Reports|September 15, 2025
Comorbidities and apolipoprotein E genotypes of patients with mild cognitive impairment in transition to Alzheimer's diseaseMingfei Li, Ying Wang, Lewis Kazis, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 22, 2023
Angiotensin-converting enzyme inhibitors and statins therapies-induced changes in omics profiles in humans and transgenic tau miceRoberto Collu, Elisa Giunti, Sarah Daley, et al.
Journal of Neurochemistry|March 30, 2010
In vivo manifestation of Notch related phenotypes in zebrafish treated with Alzheimer's amyloid reducing gamma-secretase inhibitorsTing Yang, Dilyara Arslanova, Xiaoyin Xu, et al.
Pageof 16

Showing results (21-30 of 152) with videos related to

Sort By:
Pageof 16
Archives of Neurology|October 14, 2009
Ten-year change in plasma amyloid beta levels and late-life cognitive declineOlivia I Okereke, Weiming Xia, Dennis J Selkoe, et al.
Metabolic Brain Disease|November 14, 2024
Individuals with SATB2-associated syndrome have impaired vitamin and energy metabolism pathwaysRoberto Collu, Yuri A Zarate, Weiming Xia, et al.
JAMA Neurology|May 3, 2016
Genomics of Alzheimer Disease: A ReviewRoger N Rosenberg, Doris Lambracht-Washington, Gang Yu, et al.
Frontiers in Molecular Neuroscience|August 28, 2020
Targeting Amyloidogenic Processing of APP in Alzheimer's DiseaseJing Zhao, Xinyue Liu, Weiming Xia, et al.
The Journal of Biological Chemistry|March 2, 2006
The cytosolic loop of the gamma-secretase component presenilin enhancer 2 protects zebrafish embryos from apoptosisHenrik Zetterberg, William A Campbell, Hong Wei Yang, et al.
Journal of Structural Biology|July 6, 2015
Molecular dynamics simulation study reveals potential substrate entry path into γ-secretase/presenilin-1Ren Kong, Shan Chang, Weiming Xia, et al.
The Journal of Biological Chemistry|May 13, 2010
A presenilin-1 mutation identified in familial Alzheimer disease with cotton wool plaques causes a nearly complete loss of gamma-secretase activityElizabeth A Heilig, Weiming Xia, Jie Shen, et al.
Journal of Alzheimer'S Disease Reports|September 15, 2025
Comorbidities and apolipoprotein E genotypes of patients with mild cognitive impairment in transition to Alzheimer's diseaseMingfei Li, Ying Wang, Lewis Kazis, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 22, 2023
Angiotensin-converting enzyme inhibitors and statins therapies-induced changes in omics profiles in humans and transgenic tau miceRoberto Collu, Elisa Giunti, Sarah Daley, et al.
Journal of Neurochemistry|March 30, 2010
In vivo manifestation of Notch related phenotypes in zebrafish treated with Alzheimer's amyloid reducing gamma-secretase inhibitorsTing Yang, Dilyara Arslanova, Xiaoyin Xu, et al.
Pageof 16